Add to ORKGThe extensive use of prostate-specific antigen as a general prostate cancer biomarker has introduced the hazards of overdiagnosis and overtreatment. Recent studies have revealed the immense biomarker capacity of microRNAs (miRNAs) in prostate cancer. The aim of this study was to analyze the expression pattern of miR-224, a cancer-related miRNA, in prostate tumors and investigate its clinical utility
Background Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (P...
Prostate cancer is the most prevalent nonskin cancer and a major cause of cancer-related deaths worl...
MicroRNAs are key regulators of gene expression and play critical roles in both normal physiology an...
The extensive use of prostate-specific antigen as a general prostate cancer biomarker has introduced...
antigen as a general prostate cancer biomarker has in-troduced the hazards of overdiagnosis and over...
Prostate cancer is the most common malignancy among men in the US. Though considerable improvement i...
Prostate cancer (PCa) is one of the most commonly diagnosed cancers worldwide, accounting for almost...
Prostate cancer is diagnosed in over 1 million men every year globally, yet current diagnostic modal...
Prostate cancer (PCa) is one of the most commonly diagnosed cancers worldwide, accounting for almost...
Prostate cancer, one of the most common cancers among men, can be relatively harmless or extremely a...
Purpose: Aberrant expression of microRNAs (miRNAs) has been discovered in prostate cancer progressio...
Prostate cancer (PCa) is one of the leading causes of cancer deaths in men. Since there are limited ...
MicroRNAs (miRNAs) are made up of -22 endogenous nucleotides and are small, noncoding RNAs that are ...
Context: Short noncoding RNAs known as microRNAs (miRNAs) control protein expression through the deg...
© 2018 The Author(s). Prostate cancer is diagnosed in over 1 million men every year globally, yet cu...
Background Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (P...
Prostate cancer is the most prevalent nonskin cancer and a major cause of cancer-related deaths worl...
MicroRNAs are key regulators of gene expression and play critical roles in both normal physiology an...
The extensive use of prostate-specific antigen as a general prostate cancer biomarker has introduced...
antigen as a general prostate cancer biomarker has in-troduced the hazards of overdiagnosis and over...
Prostate cancer is the most common malignancy among men in the US. Though considerable improvement i...
Prostate cancer (PCa) is one of the most commonly diagnosed cancers worldwide, accounting for almost...
Prostate cancer is diagnosed in over 1 million men every year globally, yet current diagnostic modal...
Prostate cancer (PCa) is one of the most commonly diagnosed cancers worldwide, accounting for almost...
Prostate cancer, one of the most common cancers among men, can be relatively harmless or extremely a...
Purpose: Aberrant expression of microRNAs (miRNAs) has been discovered in prostate cancer progressio...
Prostate cancer (PCa) is one of the leading causes of cancer deaths in men. Since there are limited ...
MicroRNAs (miRNAs) are made up of -22 endogenous nucleotides and are small, noncoding RNAs that are ...
Context: Short noncoding RNAs known as microRNAs (miRNAs) control protein expression through the deg...
© 2018 The Author(s). Prostate cancer is diagnosed in over 1 million men every year globally, yet cu...
Background Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (P...
Prostate cancer is the most prevalent nonskin cancer and a major cause of cancer-related deaths worl...
MicroRNAs are key regulators of gene expression and play critical roles in both normal physiology an...